PALLIATIVE CARE EXPERT THOMAS J. SMITH recalls meeting with Jeanne Welch, a breast cancer patient forced to end chemotherapy early due to related nerve toxicity. Welch’s quality of life was severely diminished by chemotherapy-induced peripheral neuropathy. For five months, its effect on her hands made it challenging to hold things, and the lack of feeling in her feet made it difficult for her to walk.

Smith, the director of palliative care at Johns Hopkins Medicine in Baltimore, initiated symptom management treatments, including topical menthol and and scrambler therapy, in which electrical impulses block the transmission of pain signals through the nervous system. Almost immediately, Welch’s walking improved drastically, and her pain and tingling were cut in half.

While some patients associate palliative care with end-of-life care, or hospice, oncologists like Smith hope to reframe it as a powerful tool for all advanced cancer patients, beginning at the time of diagnosis. When used in combination with cancer treatment, it can improve quality of life for patients and their caregivers, relieve symptoms, reduce hospitalization and even extend survival.

“Based on a dozen randomized trials, every advanced cancer patient should see a palliative care team within eight weeks of diagnosis,” says Smith. “[A palliative care team] starts with symptom management and then moves on to an understanding of [the patient’s] situation, how they’re coping and what we can do practically to help. You simply can’t do that in a 15-minute oncology visit.”

But has the availability of palliative care services kept up with the need demonstrated by research? A study published February in Cancer examined how palliative care has evolved over the past decade and whether access has improved in cancer centers around the country. The results of a 2009 survey of U.S. cancer centers were contrasted with the results of an updated survey distributed to cancer centers in 2018.

The researchers compared all National Cancer Institute (NCI)-designated cancer centers in 2018 with all NCI-designated cancer centers in 2009, and a random sample of cancer centers not designated by the NCI in 2018 against a different random sample of such cancer centers in 2009. (The samples of non-NCI centers shared similar state distributions.) The study investigated the prevalence of four models of palliative care: outpatient clinics, inpatient consultation teams, institution-run hospices, and palliative care units (PCUs), which provide inpatient, intensive symptom support within a hospital.

The survey revealed a stark difference between NCI-designated cancer centers and those that do not have the designation. According to the survey, the percentage of NCI-designated cancer centers that offer outpatient palliative care services rose from 59% in 2009 to 95% in 2018, far exceeding the increase from 56% to 68% among non-NCI designated cancer centers. An NCI designation is the highest federal rating for a cancer center, typically awarded to large centers that maintain high standards of quality for research and care. There are currently 71 NCI-designated cancer centers in the U.S.

Besides the large increase in the number of outpatient clinics in NCI-designated cancer centers, no other category saw much change. NCI-designated cancer centers saw no significant change in the three other models, and cancer centers that are not NCI-designated saw no significant change in any of the four models.

“The progress is a little bit slower than I would like to see,” says David Hui, an oncologist and palliative care specialist at the University of Texas MD Anderson Cancer Center in Houston and an author of the paper. “Our hypothesis was that outpatient services would grow, and it is very encouraging that they are growing. But what is surprising is that many cancer centers in non-NCI groups don’t have outpatient services. ​​​… Given that [palliative care] appears so essential for cancer patients, I feel that this survey highlights the opportunities for further improvement.”

Patients might access each of the four models—outpatient clinics, inpatient teams, PCUs and hospices—as their needs progress and they require more care. Hui stresses the importance of outpatient clinics in allowing patients with advanced cancer to begin palliative care services early, which can have a big impact across the entire continuum of care.

“Our team has been promoting the idea of palliative care as a preventive care,” Hui says. “If we can talk to patients about how to use medicine safely and how to control pain better, maybe they won’t need to go to the hospital for a pain crisis.”

Language has also changed over the past decade. Although “palliative care” remained the most commonly used phrase to describe these services, 18 NCI-designated cancer centers and eight cancer centers not designated by the NCI began to use “supportive care” instead. Hui says that after MD Anderson changed its wording from “palliative care” to “supportive care,” referrals not only increased, but came earlier.

​“Patients are often scared to go to palliative care because they associate it with hospice,” says Smith. “I want [patients] to understand that we are here to help them. … And it’s not in lieu of their cancer care, it’s in addition to it. When it’s done that way, the benefits are legion, including improved quality of life, half the rate of anxiety and depression, much better understanding of prognosis, less caregiver distress and fewer hospitalizations.”

If a patient doesn’t have access to palliative care services at their cancer center, Smith urges them to talk with their oncologist to find nearby services or perhaps telehealth services. He also suggests visiting to learn what is available locally.

Jen Tota McGivney is a writer in Charlotte, North Carolina.